ALISO VIEJO, Calif., May  19, 2026  (GLOBE NEWSWIRE) -- (NASDAQ:RXST) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is scheduled to participate in

RXST

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

RxSight to Present at Stifel 2026 Virtual Ophthalmology Forum

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>ALISO VIEJO, Calif., May  19, 2026  (GLOBE NEWSWIRE) -- (NASDAQ:RXST) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is scheduled to participate in</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>RxSight, Inc. plans to participate in the Stifel 2026 Virtual Ophthalmology Forum on May 26, 2026. This engagement is expected to boost investor interest and highlight RxSight&#039;s innovative adjustable lens technology, potentially influencing market perception and stock performance.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>RxSight will present at the Stifel 2026 Virtual Ophthalmology Forum.</li><li>Management&#039;s fireside chat is scheduled for May 26, 2026.</li><li>The company offers unique adjustable intraocular lens technology.</li><li>Live and archived webcasts will be available on their investor site.</li><li>Participation may enhance visibility and investor interest in RxSight.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Stifel Financial Corp (SF)</strong>: Hosting the virtual forum where RxSight will present.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>This falls under &#039;Corporate Developments&#039; as it relates to a significant company presentation that could impact market sentiment.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Management&#039;s visibility at the forum may enhance investor confidence.</li><li>The unique technology could draw attention from potential partners.</li><li>Increased interest may position RXST favorably in upcoming earnings.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Event date: May 26, 2026.</li><li>Management will participate at 10:00 a.m. Pacific Time.</li><li>RxSight&#039;s technology: Adjustable intraocular lens for post-cataract surgery.</li><li>Product includes Light Adjustable Lens and Light Delivery Device.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Invest in RXST ahead of the forum for potential positive price movement.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p>ALISO VIEJO, Calif., May  19, 2026  (GLOBE NEWSWIRE) -- (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/RXST">RXST</a>) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is scheduled to participate in a fireside chat on Tuesday, May 26, 2026, at 10:00 a.m. Pacific Time. A live and archived webcast of the presentation will be available on the company's investor relations website at <a href="https://www.globenewswire.com/Tracker?data=9Ap4MlwCgtj1DC4pwP1YXYFq-z-XlMqJH_kKRCZeCYT_xAlAtZFkFw0nICLSfF82s7UgpcGsj0-4aFOG6A6ivktrc3i6c_z1vlw26B8hD9-Qkk-ocRycKg_Taz2HcWqW" rel="nofollow" target="_blank">https://investors.rxsight.com/</a>.</p>  <p><strong>About RxSight, Inc.</strong></p>  <p>RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight<sup>&#xAE;</sup> Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens<sup>&#xAE;</sup> (LAL<sup>&#xAE;</sup>/LAL+<sup>&#xAE;</sup>, collectively the "LAL"), RxSight Light Delivery Device (LDD&#x2122;) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at <a href="https://www.globenewswire.com/Tracker?data=J13lEioNYxchK4Vx35lJ6ES9nW7YjYFSYfK0b0iyUhjLhm8cZM-qEYZYh0CPXW4x_bc2nmvyU4_gKvmMhsSHKA==" rel="nofollow" target="_blank">www.rxsight.com</a>.</p>  <p><strong>Investor Relations Contact:</strong><br></br>Oliver Moravcevic<br></br>VP, Investor Relations<br></br><a href="https://www.globenewswire.com/Tracker?data=2RZs6tLXiVCD8FoYq2KjBrGKNMT5H365q4qMoA_igM4V9vxsAtasdBULiuyB0olN_EevloHUmj4s60ZnEV7xun8RpDUAMeRb6mKyX_yTyeI=" rel="nofollow" target="_blank">omoravcevic@rxsight.com</a></p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTcyMzE1MiM3NjExNTM1IzIyMTAxNDU="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/NjlkYThmYmItMTJiNi00M2Q2LTg1OTYtNWJkNTUxZmQwNTQ5LTEyMjE2OTgtMjAyNi0wNS0xOS1lbg==/tiny/RxSight-Inc-.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/48441335-c938-45ff-9355-ba8e331354e9"><img src="https://ml.globenewswire.com/media/48441335-c938-45ff-9355-ba8e331354e9/small/rxsight-globe-png.png" border="0" width="150" height="46" alt="Primary Logo"></img></a></p>

RxSight, Inc. plans to participate in the Stifel 2026 Virtual Ophthalmology Forum on May 26, 2026. This engagement is expected to boost investor interest and highlight RxSight's innovative adjustable lens technology, potentially influencing market perception and stock performance.

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News